Medicines products | Average monthly day of stock out (days) | ||
---|---|---|---|
Overall | Before COVID-19 | During COVID-19 | |
Insulin products | 10.5(7–12.5) | 7.6 (4.4–13.2) | 13(9.5–18) |
Oral hypoglycemic agents | 8.7(5- 11.5) | 8.7 (2.3–12) | 10.6(4–14) |
Aspirin | 12.5(8.2–16.8) | 9 (6–14) | 16(10–23) |
Diuretics | 6.6(4.2–9) | 5.5 (3–8) | 7.4 (4.2–10.6) |
Beta-blockers | 7.7 (6.3–9) | 6.5 (5.6–7.4) | 8.6 (7.8–9.5) |
ACE inhibitors/ARBs | 7.7(6–9.5) | 5.3(2.2–8.4) | 9(5–13.4) |
Statins | 11.6 (9.4–13.8) | 8.6(6.8–10.4) | 13.6(11.6–15.8) |
Calcium Channel blockers | 6.6 (5.3–7.9) | 4.7(3.5–6.7) | 7.9 (6–9.7) |
Digoxin products | 9.5 (5.8–13.2) | 8.8 (5.6–12.4) | 10.4(7.2–13.6) |
Methyldopa | 16 (10.6–21.4) | 13(8.7–17.3) | 16(14.6–21.4) |